Abstract | INTRODUCTION: AREAS COVERED: In this review, the authors discuss the limitations of the current opioid and non-opioid analgesic options. They also review the pharmacokinetics of oliceridine, its analgesic efficacy, and risk of adverse events; and its added clinical value in managing moderate to severe pain. EXPERT OPINION:
|
Authors | Zhaosheng Jin, Mingxi Zhu, Abhishek Gupta, Christopher Page, Tong J Gan, Sergio D Bergese |
Journal | Expert opinion on pharmacotherapy
(Expert Opin Pharmacother)
Vol. 23
Issue 1
Pg. 9-17
(Jan 2022)
ISSN: 1744-7666 [Electronic] England |
PMID | 34534033
(Publication Type: Journal Article, Review)
|
Chemical References |
- ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
- Analgesics, Opioid
- Spiro Compounds
- Thiophenes
- Morphine
|
Topics |
- Acute Pain
(drug therapy)
- Adult
- Analgesics, Opioid
(adverse effects)
- Humans
- Morphine
- Pain, Postoperative
(drug therapy)
- Postoperative Nausea and Vomiting
- Spiro Compounds
- Thiophenes
|